EURETINA and Oculis have come together to pay a lasting tribute to Professor Tadayoni’s legacy. In this effort, EURETINA has established the Ramin Tadayoni Award supported by Oculis. Professor Tadayoni was a world-renowned retina specialist who contributed greatly to the field of ophthalmology and to Oculis’ success as Retina Chair of the company’s Scientific Advisory Board and as Chief Scientific Officer, at the time of his unexpected passing earlier this year. Throughout his career, Professor Tadayoni was highly committed to advancing retinal research and education. This annual award will combine both of these profound values by supporting the next generation of talented ophthalmologists who have demonstrated outstanding potential in retinal research and are driving forward innovation in the field. For additional details on this announcement, see our press release here: https://bit.ly/4ezIZY9 For more information about the Ramin Tadayoni Award, including eligibility requirements and how to apply, visit: https://lnkd.in/eFgZen6f #eyehealth #ophthalmology #biotech #biopharma #eyedisease #education #researchgrant
Oculis’ Post
More Relevant Posts
-
Clinician Scientist | Head of Research @ LVPEI | Cornea, Ocular Surface, & Stem Cells | Strategist & Mentor
To me, numbers and rankings are not just about where we are today, but also about where we could be tomorrow. L V PRASAD EYE INSTITUTE (LVPEI) is currently ranked among the top ten global eye research institutes, a testament to our excellence and commitment to advancing the field. The SCImago annual rankings and Stanford lists are pivotal in this regard, serving as independent validations by globally recognized organizations. They evaluate us based on established metrics from publicly accessible and accredited databases. The SCImago rankings, in this context, can be seen as the academic equivalent of the Fortune 500 for businesses or the FIFA/ATP rankings in sports. These accolades are not just about celebrating what we've achieved but are also a beacon guiding us towards what we aspire to become. I am incredibly grateful and proud to work alongside an exceptional team of researchers at LVPEI, particularly the remarkable women who consistently strive for excellence. Together, we are not just challenging the status quo but also redefining it, every single day. https://lnkd.in/gkcyBtRB #LVPEI #SCImago #Research #Innovation #Sothatallmaysee #Impact
#SCImagoInstitutionsRanking 2024 For the third consecutive year, LVPEI has been recognized among the top ten global eye research institutions in the SCImago Institutions Rankings! 🎉 Ranked sixth globally (up two spots from 2023), third in Asia, and first in India in the ophthalmology category, LVPEI remains a leader in vision sciences research. 🌍🔬 SCImago Institutions Rankings evaluates institutions worldwide based on research output, innovation, and societal impact, including research publications, patents, and social media conversations. This achievement underscores our commitment to advancing research and improving patient outcomes. #LVPEI #EyeResearch #VisionScience #TopTen #SCImagoRankings #SoThatAllMaySee
To view or add a comment, sign in
-
Research Assistant III at Cincinnati Children’s Hospital Medical Center Hematopoiesis | Hematopoietic stem cells | Cellular Therapy |
I am thrilled to announce the publication of my co-first author research paper, titled “Evidence for the involvement of keratinocyte-derived microvesicle particles in the photosensitivity associated with xeroderma pigmentosum type A deficiency” in the journal of Photochemistry and Photobiology. Our study delves into the intricacies of XPA deficiency, uncovering crucial insights into the role of keratinocytes-derived microvesicle particles (MVP) in the associated photosensitivity. By investigating the roles of platelet-activating factor (PAF) and acid sphingomyelinase (aSMase) in triggering MVP release, our research sheds light on promising therapeutic targets for XPA-related photosensitivity. The full text is accessible at DOI: https://lnkd.in/dfrcB_f8 This research is supported by National Institute of Health (NIH): R01 ES031087; National Institute of General Medical Sciences: R01GM130583; U.S. Department of Veterans Affairs to Dr. Jeffrey B. Travers, M.D., Ph.D., FAAD. Gratitude to my co-authors/ lab members Rushabh Lohade Shikshita Singh for their invaluable contributions and special acknowledgment to my Principal Investigator, Dr. Jeffrey B. Travers, M.D., Ph.D., FAAD, for his unwavering support and mentorship. Your guidance has been instrumental throughout my research journey. #researchpublication #dermatology #scientificdiscovery
To view or add a comment, sign in
-
Last month, I successfully defended my PhD in Biomedical Engineering at The University of Illinois Chicago :) Gratitude to my incredible advisors Yannek Leiderman, Darvin Yi, and Cristian Luciano, Ph.D. for their guidance and support throughout this 5-year journey! If you want to take a look at how AI can revolutionize ophthalmic microsurgery, here are some of my papers (more to come!): https://lnkd.in/eVftJmDz https://lnkd.in/gagaduut https://lnkd.in/g9nKW3jc Additional papers, patents, and conference abstracts can be found on my Scholar profile: https://lnkd.in/e3GBufby #digitalsurgery #biomedicalengineering #ophthalmology #deeplearning #computervision
To view or add a comment, sign in
-
Cynthia Owsley, PhD, Gerald McGwin, Jr., PhD, and fourth-year resident Poojitha Balakrishnan, MD, PhD, MPH validated timed instrumental activities of daily living (TIADL) tasks as an objective measure for adults with irreversible vision impairment in their recent BMC Ophthalmology article "Timed instrumental activities of daily living tasks in adults with irreversible vision impairment: validation to visual function and self-report." Their study involved 88 patients from UAB’s Department of Ophthalmology and Visual Sciences and found that longer task completion times correlated with decreased visual acuity, contrast sensitivity, and visual field. TIADL scores were also significantly associated with self-reported abilities in reading-related tasks, making TIADL a valuable complement to self-reported measures in clinical and research settings. Read more: https://lnkd.in/eQZGzd5R
To view or add a comment, sign in
-
Medical & Scientific Writer | Clinical & Regulatory Affairs Specialist | Medical Devices | Researcher 👁️ | Beginner Runner 🏃🏼♀️ | Mosaic Lover 🟪🟩
Proud to be part of this team! At Retinai, the Research Team is dedicated to elevating your research & data analysis with the efficiency our AI technology enables. Whether you are focused on clinical trials, drug development or academia, we are here to offer technology solutions that are tailored to your needs. Check out our most recent Blog Post to see how can we help you elevate your #research and #dataanalysis! Joseph Blair, Adrian Kaufmann, Sandro De Zanet #research #ophthalmology #AI
How can Retinai Discovery® take your research and data analysis to the next level? Our platform streamlines your clinical trials and academic research with a smooth 3-step process: 1️⃣ Planning 2️⃣ Analysis 3️⃣ Reporting Find out how we customize our AI-driven solutions to fit your unique needs and advance your work in ophthalmology. Explore the benefits of collaborating with Retinai and how we can enhance your research outcomes in our latest blog 👉 https://lnkd.in/enjxzVjF #Innovation #HealthTech #EyeHealth Romina Lasagni Vitar, PhD Joseph Blair
To view or add a comment, sign in
-
I’m thrilled to share that our latest study, "Myopia and Systemic Manifestations of Tissue Hyperlaxity: A Population-Based Cross-Sectional Study," has been published in Clinical and Experimental Ophthalmology! In this research, we explored the association between myopia and systemic signs of connective tissue hyperlaxity among adolescents. Our findings, based on a large cohort of over 920,000 adolescents, show that those with myopia had a higher prevalence of conditions like hernias, pes planus, and scoliosis, potentially indicating a link between myopia and systemic tissue laxity. These insights could pave the way for further exploration into the pathophysiology behind myopia formation and progression. You can find more details here: https://lnkd.in/dkRFg46P. A big thanks to my co-authors Idan Hecht and Itay Nitzan for their dedication to this project! #Research #Ophthalmology #Myopia
To view or add a comment, sign in
-
‘Origami-inspired’ folding electrodes could reduce surgery needed to treat brain conditions. A research team led by the University of Oxford and the University of Cambridge have created new ‘origami-inspired’ brain electrodes that can fold up to a fraction of their full size. This advance could significantly reduce the amount of surgery needed to treat conditions such as epilepsy, or to install brain-computer interface. Read: https://lnkd.in/ez-RtnDz #sciencesdelavie #biotechnology #biotechnology #innovation #innovations #research #sciences #medicaments #research #drugresearch #laboratories #labs #chemistry #chemistry #biology #biologie #biopharma #rna #rnatherapeutics #arn #revolution #happy
To view or add a comment, sign in
-
Associate Professor of Ophthalmology, Retina Imaging Expert, Medical Retina Specialist, Chief Medical Officer at Altris, Inc. (Altris AI & Altris Education), Ophthalmic Clinic Owner
Let's talk about AI for OCT analysis at The European Society of Cataract and Refractive Surgeons (ESCRS).
ESCRS Booth Event! Dear Partners, Optohellas is excited to invite you to our 2-day event in our #Booth_7A100 at #ESCRScongress in Barcelona. Dr. Maria Znamenska, MD, PhD 🇺🇦, Associate Professor of Ophthalmology & Chief Medical Officer at Altris AI will be there to discuss AI for OCT Interpretation & Quantitative Progression Tracking and answer any questions you may have. Please complete the form below to express your interest in attending. https://lnkd.in/dxeF-ytd We look forward to seeing you there! #Redefine_Vision_Together #Join_Optohellas_World_Partners_Network #Visit_Booth_7A100_ESCRS_Barcelona Altris AI Optohellas Andrey Kuropyatnyk, MBA Maria Znamenska, MD, PhD 🇺🇦 Oleksandra Krasovska Olha Shyrykhalova🇺🇦 Mark Braddon Christos Papanikolaou Vaggelis Fitas Christine Tsini Theodoros Georgiadis Dimitris Vasiageorgis Konstantinos Malamidis Giannis Tsoukalis Anastasios Theodorou John Haliabalias Spiros Pougounas Vasileios Grammatikopoulos Ellie Lapsana Ioanna Avakian Dimitrios Konstantopoulos John Sotiropoulos #ESCRS_2024 #ArtificialIntelligence #OCT
To view or add a comment, sign in
-
Noninvasive eye drop therapy: Is this the future of keratoconus care? Last week, Ehsan Sadri MD FACS of the Visionary Eye Institute in Newport Beach, California, sat down with Professor Emeritus Colin Green (PhD, DSc) from The University of Auckland, to learn more about TheiaNova Limited's novel therapy in development for the treatment of keratoconus and other corneal ectasias. Listen to their conversation on the Ophthalmology Times podcast below and learn more about TheiaNova at www.theianova.com
To view or add a comment, sign in
-
R&D and Innovation expert, 3D printing, Optics, Lasers, PhD in Physics, international and multisectoral environment, DLP
A #gel for #3Dprinting of artificial #organs was created in #Ufa. Thanks to it, the process of selecting implants can speed up The technology for obtaining the main substance of #bioink was developed by an initiative group of students from Bashkir State Medical University (BSMU). Thanks to their research, the process of selecting implants for patients in need of transplantation may become faster. “We use dispersed collagen, processed in a special way, and it is mixed with water in a certain concentration,” explains medical scientist @Akhunzyanov Azat. The gel contains no toxic chemical additives, and collagen is similar to human #collagen. The development is based on a biological material for #RegenerativeSurgery and therapy, which was discovered by ophthalmologist #ErnstMuldashev. As the scientific director of the initiative group, @Kabirov Ildar, explained, the biogel created by the students is #notdiscovery, but an #innovation in the field of #medicine. The second component of bioink is #livingcells grown separately in cell culture. “In the future, this may lead to the fact that we will #notuseanimals, like rats, for example, now, but create artificial human-like models and train on them,” says @Neryakhin Alexandre, head of the #student_initiative_group. Now it is possible to print #flatorgans and #cartilage. The first sample according to the students' plans will be the cartilage of the nasal septum. "In the coming decades, it is planned to print #tubularorgans, such as the intestines, for example. We assume that the region will develop actively. In particular, this will affect the areas of transplantology, oncology and surgery,” adds @Ekaterina Nadezhdina, a member of the initiative group. #Bashkortostan #Russia #ALLOINK, CELLINK, @Polina Schmelkova https://lnkd.in/eNj38XkH
To view or add a comment, sign in
3,960 followers